Brookstone Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
15,551
+12,489
| +408% | +$1.04M | 0.02% | 504 |
|
|
2025
Q1 | $248K | Buy |
3,062
+391
| +15% | +$31.7K | ﹤0.01% | 920 |
|
|
2024
Q4 | $241K | Sell |
2,671
-412
| -13% | -$37.1K | ﹤0.01% | 893 |
|
|
2024
Q3 | $305K | Sell |
3,083
-16,122
| -84% | -$1.59M | ﹤0.01% | 832 |
|
|
2024
Q2 | $1.92M | Buy |
19,205
+16,213
| +542% | +$1.62M | 0.03% | 377 |
|
|
2024
Q1 | $284K | Buy |
+2,992
| New | +$284K | 0.01% | 784 |
|
|
2022
Q3 | – | Sell |
-10,354
| Closed | -$874K | – | 837 |
|
|
2022
Q2 | $874K | Buy |
+10,354
| New | +$874K | 0.02% | 437 |
|
|
2021
Q1 | – | Sell |
-14,048
| Closed | -$1.98M | – | 557 |
|
|
2020
Q4 | $1.98M | Sell |
14,048
-3,745
| -21% | -$527K | 0.08% | 174 |
|
|
2020
Q3 | $1.98M | Buy |
+17,793
| New | +$1.98M | 0.09% | 145 |
|